The clinical implication: aggressive dose escalation in lower-BMI users is the tolerability problem, not the compound itself
Outcomes To investigate the long-term clinical and economic outcomes of various anti-diabetic treatments, researchers utilized the CORE diabetes (Center for Outcomes and Resource Evaluation) model, which simulates morbidity, mortality, and associated healthcare costs based on epidemiological data from extended clinical trials (16)(17)
Epithalon Epithalon (Epitalon) is a synthetic tetrapeptide studied for its potential role in telomerase activation and cellular aging regulation
GLP-1 analogues, such as semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide, have emerged as powerful tools in the battle against obesity and diabetes